Clinical trial
Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary…
NCT00313222 · Actelion, Industry · Completed
Key facts
| NCT number | NCT00313222 |
|---|---|
| Title | Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension |
| Official title | Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) |
| Lead sponsor | Actelion, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Thromboembolic Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | bosentan |
| Enrollment | 157 |
| Start date | Oct 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Apr 12, 2006 |
| Last update posted | Feb 3, 2025 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: